182 related articles for article (PubMed ID: 8879118)
1. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.
Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M
Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118
[TBL] [Abstract][Full Text] [Related]
2. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
3. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
Katich SC; Zerfass-Thome K; Hoffmann I
Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
[TBL] [Abstract][Full Text] [Related]
5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE
J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
Zerfass K; Levy LM; Cremonesi C; Ciccolini F; Jansen-Dürr P; Crawford L; Ralston R; Tommasino M
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
[TBL] [Abstract][Full Text] [Related]
8. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
9. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
Arroyo M; Bagchi S; Raychaudhuri P
Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
11. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
Lam EW; Morris JD; Davies R; Crook T; Watson RJ; Vousden KH
EMBO J; 1994 Feb; 13(4):871-8. PubMed ID: 8112300
[TBL] [Abstract][Full Text] [Related]
12. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein.
Vogt B; Zerfaß-Thome K; Schulze A; Botz JW; Zwerschke W; Jansen-Dürr P
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2103-2113. PubMed ID: 10466809
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
[TBL] [Abstract][Full Text] [Related]
16. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.
Melillo RM; Helin K; Lowy DR; Schiller JT
Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
19. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
20. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.
Schulze A; Mannhardt B; Zerfass-Thome K; Zwerschke W; Jansen-Dürr P
J Virol; 1998 Mar; 72(3):2323-34. PubMed ID: 9499093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
